PRIMA implant helps 80% of macular degeneration patients regain vision

A new study published in the New England Journal of Medicine found that the PRIMA brain-computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some central vision. The device uses a tiny 2 millimeter by 2 millimeter photovoltaic implant that is only 30 micrometers thick and thinner than a strand of hair. It sits under the retina and works with a special pair of smart glasses. The glasses capture images and send them as near-infrared light to the implant. The implant converts this light into small electrical signals that stimulate the optic nerve. This process mimics the way healthy retinal cells normally send visual information to the brain.

The study followed thirty-eight participants, thirty-two of whom completed a one-year follow-up. Twenty-six patients experienced measurable improvement in their vision, which equates to approximately eighty percent of the group. Many participants were able to reread letters, numbers and even entire pages of text. Although the restored vision is black and white and slightly blurry, the results are remarkable for people who once believed they would never see clearly again.

WORLD’S THINNEST AI GLASSES INCLUDE BUILT-IN AI ASSISTANT

Sign up for my FREE CyberGuy Report
Get my best tech tips, urgent security alerts and exclusive offers straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM bulletin.

Why it is important for the treatment of AMD

Age-related macular degeneration, often called AMD, is a leading cause of irreversible blindness in older adults. Until now, available treatments could only slow vision loss. None of them could restore what had already been lost.

The PRIMA implant works with smart glasses to bring central vision back to life. (PRIMA by Science)

The PRIMA implant takes a different approach. It directly replaces the missing function of the retina by transforming light into electrical signals. Patients can still use their natural peripheral vision while the implant restores some central vision. This combination creates a more complete visual experience.

The trial showed that the operation is generally safe. Most side effects occurred within the first two months and went away shortly after. Importantly, the implant did not reduce the patients’ remaining natural peripheral vision. Researchers consider this a major step toward restoring eyesight rather than simply slowing its decline.

The PRIMA implant was developed by Science Corporation, a brain-computer interface company founded by Max Hodak, co-founder of Neuralink. Science Corporation acquired PRIMA technology from French company Pixium Vision, continuing its development towards clinical use.

EYE DROPS CAN REPLACE READING GLASSES FOR THOSE WITH AGE-RELATED VISION LOSS

The small chip sits under the retina and transforms light into visual signals. (PRIMA by Science)

What does this mean for you

If you or someone you love is living with advanced AMD, this breakthrough could offer real hope. For the first time, there is a device that can restore some sight instead of just preserving what’s left. You may wish to discuss upcoming trials or future approval of the PRIMA system in your area with your ophthalmologist. The company behind this technology has already applied for European approval and a process with the US Food and Drug Administration is underway.

Regaining central vision, even partial, can make a big difference. Reading text, recognizing faces or simply moving around independently becomes possible again. These advances also show how quickly medical innovation is evolving. Patients who were once told nothing could help them may soon have the chance to see again.

It’s also a reminder to stay informed. Once-experimental treatments are becoming available sooner than expected. Discussing new technologies with your doctor helps you understand timing, eligibility, and the type of results you can reasonably expect.

This breakthrough offers new hope for people living with advanced macular degeneration. (PeopleImages/Getty Images)

Take my quiz: How safe is your online security?

Do you think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get personalized analysis of what you’re doing right and what needs improvement. Take my quiz here: CyberGuy.com.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Kurt’s Key Takeaways

The PRIMA retinal implant represents a shift in the way scientists and doctors view blindness caused by AMD. For decades, the focus has been on slowing the disease. Today, researchers prove that restoration is possible. Although this generation of implants provides limited black and white vision, it provides real, functional vision to people who previously did not have vision. This alone changes lives. There is still work to be done to improve image clarity, color perception and comfort. However, this is only the beginning. Future versions of the device and smart glasses could make vision restoration even more effective and accessible.

If you could regain even part of your sight thanks to new technologies, would you seize the opportunity and experience the world in a whole new way? Let us know by writing to us at CyberGuy.com.

Sign up for my FREE CyberGuy Report
Get my best tech tips, urgent security alerts and exclusive offers straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM bulletin.

Copyright 2025 CyberGuy.com. All rights reserved.